Top 19 OncoMyx Therapeutics investors
The most complete profiles first. Showing 19 of 19.
Debbie LinVerified
Venture Capital, Corporate Venture Capital, Investor · United States
SeedHealth CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 36 more
Verified email available
Johannes ZanzingerVerified
Venture Capital, Corporate Venture Capital, Investor · Germany
Series BSeries AHealth CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 36 more
Verified email available
Jonathan LimVerified
Venture Capital, Private Equity Firm, Finance Operator · United States
Series BHealth CareWomen FoundedEnterprise SoftwareTransportationPortfolio: Black Diamond Therapeutics, Ignyta, Flex Pharma, Independa and 6 more
Verified email available
Martin HeideckerVerified
Venture Capital, Corporate Venture Capital, Private Equity Firm · United States
SeedHealth CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 36 more
Verified email available
Alan CheahVerified
Venture Capital, Private Equity Firm · Malaysia
Health CareGeneticsWellnessWomen FoundedPortfolio: Liquidia Technologies, invendo medical, Aria CV, Gevo and 12 more
Verified email available
Detlev MennerichVerified
Corporate Venture Capital · Germany
Health CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more
Verified email available
Henry ChenVerified
Venture Capital, Private Equity Firm · Hong Kong
Health CareWearablesWellnessWomen FoundedPortfolio: Imperative Care, Rejoni, Intrinsic Therapeutics, Clover Biopharmaceuticals and 5 more
Verified email available
Oliver Reuss
Venture Capital, Corporate Venture Capital, Investor · Germany
Series BSeries AHealth CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more
Contact details available
Sebastian Kreuz
Venture Capital, Corporate Venture Capital, Investor · Germany
Series BSeries AHealth CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more
Contact details available
Fares Zahir
Venture Capital, Private Equity Firm · Malaysia
Health CareGeneticsWellnessWomen FoundedPortfolio: Liquidia Technologies, invendo medical, Aria CV, Gevo and 12 more
Contact details available
Ilka Wicke Dr.
Corporate Venture Capital · Germany
Health CareHospitalsWellnessWomen FoundedPortfolio: Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics and 35 more
Contact details available
James Tee
Venture Capital · Malaysia
Health CareGeneticsWellnessWomen FoundedPortfolio: Liquidia Technologies, invendo medical, Aria CV, Gevo and 12 more
Contact details available
Jason Rushton
Venture Capital · Malaysia
Health CareGeneticsWellnessWomen FoundedPortfolio: Liquidia Technologies, invendo medical, Aria CV, Gevo and 12 more
Contact details available
Wei Ling Goh
Venture Capital · Malaysia
Health CareGeneticsWellnessWomen FoundedPortfolio: Liquidia Technologies, invendo medical, Aria CV, Gevo and 12 more
Contact details available
Matt Constantino
Venture Capital, Private Equity Firm · United States
Health CareWearablesWellnessWomen FoundedPortfolio: Imperative Care, Rejoni, Intrinsic Therapeutics, Clover Biopharmaceuticals and 5 more
Contact details available
Michael Rakiter
Venture Capital, Private Equity Firm · United States
Health CareWearablesWellnessWomen FoundedPortfolio: Imperative Care, Rejoni, Intrinsic Therapeutics, Clover Biopharmaceuticals and 5 more
Contact details available
Sampson Lau
Venture Capital, Private Equity Firm · Hong Kong
Health CareWearablesWellnessWomen FoundedPortfolio: Imperative Care, Rejoni, Intrinsic Therapeutics, Clover Biopharmaceuticals and 5 more
Contact details available
Tim Xiao, CFA, FRM
Venture Capital, Private Equity Firm
Health CareWearablesWellnessWomen FoundedPortfolio: Imperative Care, Rejoni, Intrinsic Therapeutics, Clover Biopharmaceuticals and 5 more
Contact details available
Kanad DasVerified
Venture Capital, Investor · United States
Series BSeries ABiotechnologyPharmaceuticalsPortfolio: OncoMyx Therapeutics, Actym Therapeutics, Inc.
Verified email available
By investment stage
By location
Related industries
Most-backed portfolio companies
- ImCheck Therapeutics7
- Abalos Therapeutics7
- Actym7
- Amal Therapeutics7
- eTheRNA immunotherapies7
- T-knife7
- T3 Pharmaceuticals7
- Rgenta Therapeutics7
- Okairos7
- Brainomix7
- Hookipa Pharma7
Frequently asked questions
How many OncoMyx Therapeutics investors are on Angel Roster?
Angel Roster lists 19 OncoMyx Therapeutics investors. 8 of them (42%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (17), Private Equity Firms (9) and Corporate Venture Capital Firms (7). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do OncoMyx Therapeutics investors invest in?
Among those that list a stage, the most common are Series B (5), Series A (4) and Seed (2).
Where are OncoMyx Therapeutics investors based?
Most are based in the United States (6), Malaysia (5) and Germany (5).
Which companies have OncoMyx Therapeutics investors backed?
The most-backed portfolio companies among them are ImCheck Therapeutics (7), Abalos Therapeutics (7), Actym (7), Amal Therapeutics (7) and eTheRNA immunotherapies (7).
How do I contact OncoMyx Therapeutics investors?
Create a free Angel Roster account to search and filter all 19, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.